A prospective and retrospective analysis of smoking behavior changes in ever smokers with high risk for lung cancer from New Mexico and Pennsylvania.
- 1 June 2016
- journal article
- Vol. 7 (2) , 95-104
Abstract
Cigarette smoking is the leading preventable cause of death worldwide. The aim of this study is to conduct a prospective and retrospective analysis of smoking behavior changes in the Lovelace Smokers Cohort (LSC) and the Pittsburgh Lung Screening Study cohort (PLuSS). Area under the curve (AUC) for risk models predicting relapse based on demographic, smoking, and relevant clinical variables was 0.93 and 0.79 in LSC and PLuSS, respectively. The models for making a quit attempt had limited prediction ability in both cohorts (AUC≤0.62). We identified an ethnic disparity in adverse smoking behavior change that Hispanic smokers were less likely to make a quit attempt and were more likely to relapse after a quit attempt compared to non-Hispanic Whites. SNPs at 15q25 and 11p14 loci were associated with risk for smoking relapse in the LSC. Rs6495308 at 15q25 has a large difference in minor allele frequency between non-Hispanic Whites and Hispanics (0.46 versus 0.23, P<0.0001) and was associated with risk for ever relapse at same magnitude between the two ethnic groups (OR=1.36, 95% CI=1.10 to 1.67 versus 1.59, 95% CI=1.00 to 2.53, P=0.81). In summary, the risk prediction model established in LSC and PLuSS provided an excellent to outstanding distinguishing for abstainers who will or will not relapse. The ethnic disparity in adverse smoking behavior between Hispanics and non-Hispanic Whites may be at least partially explained by the sequence variants at 15q25 locus that contains multiple nicotine acetylcholine receptors.Keywords
This publication has 21 references indexed in Scilit:
- 15q12 Variants, Sputum Gene Promoter Hypermethylation, and Lung Cancer Risk: A GWAS in SmokersJNCI: Journal of the National Cancer Institute, 2015
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trialThe Lancet Respiratory Medicine, 2015
- A genomewide association study of smoking relapse in four European population-based samplesPsychiatric Genetics, 2013
- Smoking cessation in patients with respiratory disease: existing treatments and future directionsThe Lancet Respiratory Medicine, 2013
- Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behaviorNature Genetics, 2010
- Genome-wide meta-analyses identify multiple loci associated with smoking behaviorNature Genetics, 2010
- Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST)Thorax, 2008
- Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screeningCancer, 2005
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Duration of Smoking Abstinence and Success in QuittingJNCI: Journal of the National Cancer Institute, 1997